Teva Pharmaceuticals USA: Drug Recall
Recall #D-0520-2022 · 01/10/2022
Class II: Risk
Recall Details
- Recall Number
- D-0520-2022
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Teva Pharmaceuticals USA
- Status
- Terminated
- Date Initiated
- 01/10/2022
- Location
- Parsippany, NJ, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,175 Bottles
Reason for Recall
Failed Dissolution Specifications; Low Out of specification (OOS) results for dissolution.
Product Description
Tretinoin Capsules, 10 mg, 100 count bottle, Rx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0555-0808-02
Distribution Pattern
nationwide in the USA
Other Recalls by Teva Pharmaceuticals USA
- Class II: Risk 01/18/2022
- Class III: Low Risk 01/07/2022
- Class III: Low Risk 01/07/2022
- Class II: Risk 12/31/2021
- Class II: Risk 12/31/2021
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.